Skip to main content
. 2023 Apr 17;313:104062. doi: 10.1016/j.resp.2023.104062

Table 1.

Differences based on VO2 Maximum Exercise Capacity Criterion.

Total Sample VO2 peak > 84% pred VO2 peak ≤ 84% pred p-value
n (%) 59 35 (59) 24 (41)
Age, years 53.9 (15) 54.7 (15.8) 52.7 (14) 0.61
Sex (%) 0.371
Male 34 (57.6) 18 (51.4) 16 (66.7)
Female 25 (42.4) 17 (48.6) 8 (33.3)
Race (%) 0.183
White 29 (50.0) 21 (61.8) 8 (33.3)
African American 10 (17.2) 5 (14.7) 5 (20.8)
Asian 5 (8.6) 1 (2.9) 4 (16.7)
Chinese 2 (3.4) 2 (5.9) 0 (0.0)
Filipino 4 (6.9) 2 (5.9) 2 (8.3)
Latino 6 (10.3) 2 (5.9) 4 (16.7)
Other 2 (3.4) 1 (2.9) 1 (4.2)
Weight loss post-COVID-19 (lbs.) 14.4 (14.3) 17.4 (14.4) 15 (14.5) 0.457
Hospitalized (%) 32 (56.1) 18 (52.9) 14 (60.9) 0.749
Inpatient rehabilitation (%) 21 (36.8) 12 (35.3) 9 (39.1) 0.988
ICU (%) 23 (41.8) 12 (37.5) 11 (47.8) 0.625
Mechanical ventilation (%) 20 (36.4) 11 (34.4) 9 (39.1) 0.938
Days from hospital discharge 69 (57–143) 64 (55.2–98) 125 (69–146) 0.211
Days from positive COVID-19 test diagnosis 167 (68.8) 159.3 (68.1) 177.8 (70) 0.332
Length of stay, days 38.1 (26.9) 32.8 (23.2) 44.9 (30.7) 0.249
Days in ICU 13.5 (10.3) 12.9 (11.4) 16 (5.7) 0.614
FVC % pred 74 (64–90) 80 (69–94) 63.5 (54.2–81.5) 0.003
FEV1% pred 82.2 (18.5) 88.1 (15.9) 73.6 (18.8) 0.004
FEV1/FVC 85.2 (8) 84.5 (7.7) 86.3 (8.4) 0.407
PEF % pred 95 (83.5–106.5) 102 (91–110) 85 (77–95) 0.001
FEF 25–75% 100 (82.5–118.5) 102 (85.5–118.5) 96.5 (80.2–117) 0.436
Performance
VO2peak (ml/kg/min) 21.8 (6.1) 24.3 (5.2) 18.2 (5.6) < 0.001
VO2peak (ml/kg/min) % pred 89.2 (22.2) 104.2 (12.5) 67.4 (13.1) < 0.001
VO2 AT (ml/kg/min) 12.2 (3) 13.3 (2.7) 10.6 (2.7) < 0.001
Anaerobic threshold (AT/predicted VO2 max x 100) 57.4 (8.8) 55.7 (8.1) 50.0 (9.2) 0.069
Actual MET 6.2 (1.7) 7 (1.5) 5.2 (1.6) < 0.001
MET pred 7.7 (2.8) 8.6 (2.4) 6.5 (2.8) 0.004
Test Duration (n = 38) 7.44 (1.92) 7.88 (1.84) 6.41 (1.76) 0.031
Test Duration % pred (n = 38) 79.60 (22.26) 87.85 (20.55) 60.10 (11.55) < 0.001
Circulation
Peak systolic 162.4 (24.2) 168.7 (23.4) 153.2 (22.7) 0.017
Peak diastolic 80 (70–80) 80 (70–80) 70 (66–80) 0.242
HR reserve (beats/min) 16 (3.5–27.5) 6 (0–17.5) 27 (17–44.5) < 0.001
HR peak 149.2 (23.1) 156.7 (19) 138.3 (24.5) 0.004
HR % pred 89.8 (11.4) 94.9 (9.2) 82.3 (10.4) < 0.001
HR AT 105.9 (14.9) 107.8 (13.4) 103.2 (16.7) 0.267
HR peak % pred 71.5 (8.3) 69.1 (7.5) 75 (8.2) 0.007
Cardiovascular Function
Peak VO2/HR 11.6 (9.9–13.7) 12.4 (10.9–14.4) 10.7 (9.1–11.9) 0.002
O2 pulse peak % pred 79 (12.9) 78.6 (13.7) 79.5 (11.7) 0.772
VO2/HR AT 9.4 (2.7) 10.3 (2.7) 8.2 (2.2) 0.002
VO2/HR % pred 99.3 (21) 110.6 (13.5) 82.8 (19) < 0.001
Rate-pressure product (RPP) 22,700 (18,186–26767.5) 23,940 (22,176–28730) 18,144 (15,865–23430) < 0.001
Ventilation
Peak VE (L/min) 71.5 (24.4) 80.2 (22) 58.8 (22.4) < 0.001
VE % pred (SD) 81 (21.3) 87.1 (18.6) 72 (22.3) 0.009
VE reserve (range) 18 (4–29.5) 17 (0–24.5) 23 (5.8–37.2) 0.107
Gas exchange
VE/VCo2 AT 31.8 (29.1–35.6) 31.6 (28.6–34.6) 32.5 (29.9–38.7) 0.208
RER peak 1.11 (0.12) 1.13 (0.10) 1.08 (0.13) 0.099
SpO2 minimum 95 (94–97) 95 (94–97) 95 (92.8–98) 0.938

Note. AT: at threshold. HR: heart rate. Lbs: pounds. FVC: forced vital capacity. Min: minutes. O2: oxygen; PEF: peak expiratory flow. pred: predicted. RER: respiratory exchange ratio at end of test. RPP: rate-pressure product. VE: minute ventilation. VE/VCo2 AT: ventilatory equivalent for carbon dioxide. VO2: oxygen uptake; VO2/HR: oxygen pulse. VE/VCO2 ratio: ventilatory equivalent for carbon dioxide.